spil posts
FeedPosted Apr 27th 2009 11:50AM by Eric Buscemi (RSS feed)
Filed under: Analyst reports, Analyst upgrades and downgrades, Pfizer (PFE), Netflix, Inc. (NFLX), Analyst initiations
Analyst upgrades:
- Deutsche Bank upgraded BT Group (NYSE: BT) to Buy from Hold as it believes the company's Q4 results could remove uncertainty and cost cutting initiatives could drive upside.
- Baird upgraded Stanley Works (NYSE: SWK) to Outperform from Neutral and raised their target to $42 from $34 citing valuation, solid execution, and growth potential.
- Citigroup upgraded Netflix (NASDAQ: NFLX) to Buy from Hold as it believes the recent sell-off presents an attractive buying opportunity. The firm believes Netflix has one of the best earnings outlooks in the internet sector and increased its target price to $52 from $37.
- AstraZeneca (NASDAQ: AZN) was upgraded to Buy from Neutral at UBS.
- Joy Global (NYSE: JOYG) and Bucyrus (NYSE: BUCY) were raised to Buy from Neutral at Goldman.
Continue reading Analyst upgrades, downgrades and initiations: BT, NFLX, AZN, PFE ...
Posted Apr 20th 2009 12:00PM by Eric Buscemi (RSS feed)
Filed under: Analyst reports, Analyst upgrades and downgrades, Amazon.com (AMZN), Netflix, Inc. (NFLX), Johnson and Johnson (JNJ), Automatic Data Proc (ADP), Reliance Steel and Aluminum (RS), Palm Inc (PALM), Analyst initiations
.gif)
Analyst upgrades:
- Citigroup upgraded Amazon.com (NASDAQ: AMZN) to Buy from Hold on expectations the company's top-line growth rate could be more sustainable than expected and its operating margins could recover given due to less retail discounting. The firm raised its price target on shares to $97 from $65.
- UBS upgraded King Pharmaceuticals (NYSE: KG) to Buy from Sell based on expectations that Sandoz will settle patent litigation regarding Skelaxin after last weeks settlement of Clarinex with Schering-Plough (SGP).
- Jefferies upgraded Reliance Steel (NYSE: RS) to Buy from Hold as it believes steel prices and demand are close to near-term bottoms. The firm raised its target on the stock to $44 from $25.
- Palm (NASDAQ: PALM) was raised to Buy from Neutral at Banc of America/Merrill.
- Nestle (OTC: NSRGY) was lifted to Neutral from Underweight at JP Morgan.
- Johnson & Johnson (NYSE: JNJ) was upgraded at Wachovia to Outperform from Market Perform.
Continue reading Analyst upgrades, downgrades and initiations: AMZN, RS, JNJ, NFLX ...
Posted Mar 26th 2009 11:40AM by Eric Buscemi (RSS feed)
Filed under: Analyst reports, Analyst upgrades and downgrades, Google (GOOG), Nokia Corp. (NOK), Analyst initiations
.gif)
Analyst upgrades:
- UBS upgraded Nokia (NYSE: NOK) to Buy from Neutral as it believes the company's product portfolio is recovering.
- Canaccord upgraded Google (NASDAQ: GOOG) to Buy from Hold and raised its target to $450 from $300. The analyst said industry checks indicate deteriorating search conditions have started to improve in late March and notes that the market is already pricing in a weak Q1.
- Wachovia upgraded CGI (NYSE: GIB) to Outperform from Market Perform. In addition to valuation, the firm cited the company's defensive profile, comfort with its fiscal 2009 estimates, and its expectation that the company will continue to have strong signings.
- Siliconware Precision (NASDAQ: SPIL) was raised to Overweight from Neutral at HSBC.
- Matrixx Initiatives (NASDAQ: MTXX) was lifted to Buy from Hold at Roth Capital.
Continue reading Analyst upgrades, downgrades and initiations: NOK, GOOG, IHG, PETS ...
Posted Feb 4th 2008 10:05AM by Laurie Pasternack (RSS feed)
Filed under: Analyst upgrades and downgrades, Palm Inc (PALM)
.gif)
MOST NOTEWORTHY: Siemens , Siliconware Precision and Palm were today's noteworthy upgrades:
- Goldman upgraded Siemens AG (NYSE: SI) to Buy from Neutral and views shares as defensive in the current environment.
- Merriman upgraded shares of Siliconware Precision (NASDAQ: SPIL) to Buy from Neutral on valuation, as they believe the negative sentiment regarding the U.S. economy is already priced into shares.
- JP Morgan upgraded Palm (NASDAQ: PALM) to Overweight from Underweight citing new smart-phone products expected in 2008 and stronger-than-expected Centro sales.
OTHER UPGRADES:
- Pep Boys (NYSE: PBY) was raised to Neutral from Underperform at Credit Suisse.
- Jefferies upgraded Pioneer Drilling (NYSE: PDC) to Buy from Hold.
- Deutsche Bank upgraded Cablevision (NYSE: CVC) to Buy from Hold.
Posted Jan 29th 2008 10:28AM by Eric Buscemi (RSS feed)
Filed under: Analyst upgrades and downgrades, Toyota Motor Corp. (TM), Novell Inc (NOVL)
.gif)
MOST NOTEWORTHY: Novell, Con-Way and Flamel Technologies were today's noteworthy upgrades:
- Jefferies named Novell (NASDAQ: NOVL) its Tuesday Value Pick and upgraded shares to Buy from Hold based on expectation for revenue stabilization and gradually improving margins throughout 2008. They note the company has $3.64 in cash per share.
- JP Morgan upgraded Con-Way (NYSE: CNW) to Overweight from Neutral, citing strong execution following the company's Q4 report.
- Flamel Tech (NASDAQ: FLML) was raised to Buy from Neutral at Merriman, as they believe low expectations and the company's robust pipeline create upside the potential for upside in 2008.
OTHER UPGRADES:
- Toyota (NYSE: TM) was upgraded to Neutral from Underweight at HSBC.
- UBS upgraded Arris (NASDAQ: ARRS) to Buy from Neutral.
- BNP Paribas raised Siliconware Precision (NASDAQ: SPIL) to Buy from Hold.
Posted Nov 1st 2007 11:10AM by Eric Buscemi (RSS feed)
Filed under: Analyst reports, Analyst upgrades and downgrades, Citigroup Inc. (C), Alcatel-LucentADS (ALU)
.gif)
MOST NOTEWORTHY: Heelys, Citigroup, Alvarion, UBS AG and Alcatel-Lucent were today's noteworthy downgrades:
- CIBC downgraded Heelys (NASDAQ: HLYS) to Underperformer from Sector Performer. The analyst has little confidence sales will recover following the recent drop.
- CIBC also downgraded Citigroup (NYSE: C) to Sector Underperformer from Sector Performer, as they believe the company may have to cut its dividend, raise cash or sell assets in order to raise $30B over the near-term; the firm believes such a move would pressure shares significantly.
- Merriman downgraded shares of Alvarion (NASDAQ: ALVR) to Neutral from Buy after the in-line results as they now believe increased competition will pressure gross margins and minimize operating leverage in FY08.
- Merrill downgraded shares of UBS AG (NYSE: UBS) to Neutral from Buy to reflect the potential of further write downs.
- Banc of America lowered its rating on Alcatel-Lucent (NYSE: ALU) to Neutral from Buy to reflect poor execution of the company's turnaround strategy.
OTHER DOWNGRADES:
- Goldman removed Vimpelcom (NYSE: VIP) from its Pan European Buy List and downgraded shares to Neutral from Buy.
- Silicon Precision (NASDAQ: SPIL) was downgraded to Hold from Buy at ABN Amro.
- Lehman downgraded Amylin Pharmaceuticals (NASDAQ: AMLN) to Underweight from Equal Weight.
- Baird downgraded Dionex (NASDAQ: DNEX) to Underperform from Neutral.
Posted Sep 27th 2007 11:10AM by Eric Buscemi (RSS feed)
Filed under: Analyst reports, Aetna Inc (AET), Analyst initiations
.gif)
MOST NOTEWORTHY: Gander Mountain, Lev Pharmaceuticals, Intermune, Aetna and Medco Health were today's noteworthy initiations:
- Nollenberger initiated shares of Gander Mountain Company (NASDAQ: GMTN) with a Sell rating and $5.00 target, and believes the company's goal of reaching profitability in 2007 could prove overly optimistic.
- Lev Pharmaceuticals (OTC: LEVP) was initiated with a Sector Outperformer rating and $3 target at CIBC, as the firm believes Cinryze will likely be approved in 1Q08 and they expect the company to have significant pricing leverage.
- JP Morgan resumed coverage of Intermune Inc (NASDAQ: ITMN) with an Overweight rating and expects shares to be driven by the company's pipeline in IPF and HCV.
- Aetna Incorporated (NYSE: AET) was initiated with an Outperform rating at Wachovia. The firm feels Aetna is positioned for better growth and higher quality earnings than its peers.
- William Blair started shares of Medco Health Solutions Inc (NYSE: MHS) with an Outperform rating, as they believe an aging population, rising health care costs, and an acceleration in new product introductions should increase demand for PBM services over the next five years.
OTHER INITIATIONS:
Why do we have a weak dollar?
Holiday hiring slow for retailers
Closing Bell: What sell-off? (AIG, ABK, EPR, MBI, JAVA, ORCL, ERTS)
